Locus Cell Co., Ltd. (6891) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Locus Cell Co., Ltd. (6891:TWSE), powered by AI.

Current Price
$35.70
Sector
Unknown
What is the Locus Cell Co., Ltd. stock price forecast?

Locus Cell Co., Ltd. is currently trading at $35.70. View real-time AI analysis on Alpha Lenz.

What is Locus Cell Co., Ltd. insider trading activity?

View the latest insider trading data for Locus Cell Co., Ltd. on Alpha Lenz.

What is Locus Cell Co., Ltd.'s P/E ratio?

View Locus Cell Co., Ltd.'s valuation metrics on Alpha Lenz.

Locus Cell Co., Ltd.

TWSE · 6891
NT$35.70+0.25(+0.71%)
Ask about Locus Cell Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Locus Cell Co., Ltd.'s ROE is -11.1%. Explore profitability and growth together.

Ask for details

Company Overview

Locus Cell Co., Ltd. is a biotechnology and pharmaceutical company headquartered in New Taipei City, Taiwan. Specializing in cell therapy, the company focuses on the entrusted development and manufacturing of cell therapy-related products, serving the burgeoning life sciences tools and services sector. Founded in 2020, Locus Cell plays a role in advancing medical research and innovation in bio-therapeutic drugs, targeting critical healthcare challenges through next-generation biotechnologies. The company’s business model supports the pharmaceutical and medical research industries, collaborating on therapeutic developments that potentially address complex diseases. With a dynamic growth trajectory and increasing revenues, Locus Cell has positioned itself as a key participant in Taiwan’s biotechnology landscape, contributing to the region’s status as an innovation hub within Asia’s life sciences market. The company’s operations and output help accelerate the translation of cell-based technologies from the research stage toward clinical and commercial applications, underscoring its importance in the supply chain of cell therapy and regenerative medicine sectors.

SectorUnknown
IndustryUnknown
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$12.74MRevenue
0.00Shares Out
0Employees

Margins

49.25%Gross
-1156.18%EBITDA
-1370.51%Operating
-1425.20%Pre-Tax
-1425.20%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
-58.01%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-9.77%ROA
-11.09%ROE
-9.66%ROIC

Financial Health

NT$753.29MCash & Cash Equivalents
NT$-408.01MNet Debt
22.26%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Locus Cell Co., Ltd. (ticker: 6891) is a company listed on TWSE in the Unknown sector (Unknown).

The current price is 35.7 with a P/E ratio of -x and P/B of -x.

ROE is -11.09% and operating margin is -1370.51%. Annual revenue is $13M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Locus Cell Co., Ltd. (6891) Stock Forecast 2026 $35.70 — Price, Financials & Analyst Targets | Alpha Lenz